The Hitchhiker's Guide to Spine Awake Surgery. The Oxford SAS Protocol and Early Outcomes.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 25 11 2022
revised: 13 05 2023
accepted: 15 05 2023
medline: 9 8 2023
pubmed: 25 5 2023
entrez: 24 5 2023
Statut: ppublish

Résumé

Spine awake surgery (SAS) aims to achieve faster recovery times, better outcomes, and a lesser economic impact on society. Our drive to establish SAS was to improve patient outcomes and health economics during the COVID-19 pandemic. After a systematic review and to the best of our knowledge, SAS, the Oxford Protocol, is the first protocolized pathway that aims to train bespoke teams performing SAS safely, efficiently, and in a standardized repeatable fashion. A pilot study was designed around newly derived protocols and simulated training to determine if SAS is a safe and implementable pathway to improve patient outcomes and health economics. We assessed a cohort of 10 patients undergoing one-level lumbar discectomies and decompressions, analyzing the related costs, length of stay, complications, pain management, and patient satisfaction. The age range of our patients was 46-84 years. Three discectomies and 7 central canal stenosis decompressions were performed. Eight patients were discharged on the same day. All patients gave positive feedback about their experience of SAS. A significant cost saving was made compared to a general anesthesia (GA) overnight stay across the group. No on day cancellations occurred due to lack of bed availability. No patient needed analgesia in the recovery room or needed additional analgesia over and above the SAS e-prescription take home package. Our early experience and journey reinforce our drive to push forward and expand on this process. It aligns with the international literature which highlights this approach as safe, efficient, and economical.

Identifiants

pubmed: 37224956
pii: S1878-8750(23)00688-5
doi: 10.1016/j.wneu.2023.05.052
pmc: PMC10200716
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e289-e296

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Paolo Rizzo (P)

Department of Neurosurgery, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom. Electronic address: paolo.rizzo1@gmail.com.

Helen Hann (H)

Department of Anaesthesia, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Ben Coombs (B)

Department of Anaesthesia, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Ali Asgar Hatim Ali (AAH)

Department of Neurosurgery, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Murtuza Sikander (M)

Department of Neurosurgery, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH